Tyrosine kinase inhibitors vandetanib, lenvatinib and cabozantinib modulate oxidation of an anticancer agent ellipticine catalyzed by cytochromes P450 in vitro
Journal article published in 2018 by
Mattis Kolarik,
Radek Indra 
,
Vojtech Adam,
Zbynek Heger,
Katerina Kopeckova,
Volker M. Arlt,
Marie Stiborova
,
Vojtech Adam,
Zbynek Heger,
Katerina Kopeckova,
Volker M. Arlt,
Marie Stiborova
